| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aims and Scopes
|
|
|
2005
|
48 |
3 |
p. iii-
1 p.
|
artikel
|
| 2 |
Biological features of bronchial squamous dysplasia followed up by autofluorescence bronchoscopy [Hoshino H, et al. Lung Cancer 2004;46(2):187–96]
|
Feoli, Francesco
|
|
2005
|
48 |
3 |
p. 435-436
2 p.
|
artikel
|
| 3 |
Calendar of Events
|
|
|
2005
|
48 |
3 |
p. ix-
1 p.
|
artikel
|
| 4 |
Contents
|
|
|
2005
|
48 |
3 |
p. v-
1 p.
|
artikel
|
| 5 |
Cost-minimisation analysis comparing gemcitabine/cisplatin, paclitaxel/carboplatin and vinorelbine/cisplatin in the treatment of advanced non-small cell lung cancer in Italy
|
Novello, S.
|
|
2005
|
48 |
3 |
p. 379-387
9 p.
|
artikel
|
| 6 |
Cytological characteristics of pulmonary large cell neuroendocrine carcinoma
|
Hiroshima, Kenzo
|
|
2005
|
48 |
3 |
p. 331-337
7 p.
|
artikel
|
| 7 |
Effective detection of bronchial preinvasive lesions by a new autofluorescence imaging bronchovideoscope system
|
Chiyo, Masako
|
|
2005
|
48 |
3 |
p. 307-313
7 p.
|
artikel
|
| 8 |
EUS-guided FNA of centrally located lung tumours following a non-diagnostic bronchoscopy
|
Annema, Jouke T.
|
|
2005
|
48 |
3 |
p. 357-361
5 p.
|
artikel
|
| 9 |
Expression of the p16 INK4a gene product, methylation of the p16INK4a promoter region and expression of the polycomb-group gene BMI-1 in squamous cell lung carcinoma and premalignant endobronchial lesions
|
Breuer, R.H.J.
|
|
2005
|
48 |
3 |
p. 299-306
8 p.
|
artikel
|
| 10 |
Frequent loss of E-cadherin and/or catenins in intrabronchial lesions during carcinogenesis of the bronchial epithelium
|
Kato, Yasufumi
|
|
2005
|
48 |
3 |
p. 323-330
8 p.
|
artikel
|
| 11 |
Health-related quality of life in patients undergoing drug therapy for advanced non-small-cell lung cancer
|
Fallowfield, Lesley J.
|
|
2005
|
48 |
3 |
p. 365-377
13 p.
|
artikel
|
| 12 |
Irinotecan for malignant mesothelioma
|
Kindler, Hedy L.
|
|
2005
|
48 |
3 |
p. 423-428
6 p.
|
artikel
|
| 13 |
Phase II trial of karenitecin in patients with relapsed or refractory non-small cell lung cancer (CALGB 30004)
|
Miller, Antonius A.
|
|
2005
|
48 |
3 |
p. 399-407
9 p.
|
artikel
|
| 14 |
Polymorphisms in the promoter region of neutrophil elastase gene and lung cancer risk
|
Park, Jong Y.
|
|
2005
|
48 |
3 |
p. 315-321
7 p.
|
artikel
|
| 15 |
Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590
|
Wakelee, Heather A.
|
|
2005
|
48 |
3 |
p. 389-397
9 p.
|
artikel
|
| 16 |
Prognostication of small-sized primary pulmonary adenocarcinomas by histopathological and karyometric analysis
|
Minami, Yuko
|
|
2005
|
48 |
3 |
p. 339-348
10 p.
|
artikel
|
| 17 |
Prognostic impact of liberated domain I of the urokinase plasminogen activator receptor in squamous cell lung cancer tissue
|
Almasi, Charlotte Elberling
|
|
2005
|
48 |
3 |
p. 349-355
7 p.
|
artikel
|
| 18 |
Raltitrexed–Oxaliplatin combination chemotherapy is inactive as second-line treatment for malignant pleural mesothelioma patients
|
Porta, Camillo
|
|
2005
|
48 |
3 |
p. 429-434
6 p.
|
artikel
|
| 19 |
Randomized phase II study comparing topotecan/cisplatin administration for 5 days versus 3 days in the treatment of extensive stage small cell lung cancer (SCLC)
|
Seifart, U.
|
|
2005
|
48 |
3 |
p. 415-422
8 p.
|
artikel
|
| 20 |
Regarding Manuscript entitled: “EUS-guided FNA of centrally located lung tumours following a non-diagnostic bronchoscopy”
|
Larsen, Soeren S.
|
|
2005
|
48 |
3 |
p. 363-364
2 p.
|
artikel
|
| 21 |
Reply to Drs. F. Feoli and A.P. Meert
|
Hoshino, Hidehisa
|
|
2005
|
48 |
3 |
p. 437-438
2 p.
|
artikel
|
| 22 |
Topotecan and etoposide as first-line therapy for extensive disease small cell lung cancer: a phase II trial of a platinum-free regimen
|
Reck, Martin
|
|
2005
|
48 |
3 |
p. 409-413
5 p.
|
artikel
|
Tijdschrift beschrijving